Prescription drug · ANDA
Ursodiol NDC 70771-1407
Ursodiol 250 mg/1 · Tablet · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1407-1 | 70771140701 | 100 TABLET in 1 BOTTLE (70771-1407-1)Marketed from Nov 7, 2018 | |
| 70771-1407-5 | 70771140705 | 500 TABLET in 1 BOTTLE (70771-1407-5)Marketed from Nov 7, 2018 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ursodiol
- Generic name (nonproprietary)
- ursodiol
- Active ingredients
- Ursodiol — 250 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Zydus Lifesciences LimitedNDC labeler code 70771
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211145
- Marketing start
- Listing expires
- Other FDA classes
- Bile Acids and Salts (Chemical structure)
- Identifiers
- Product ID 70771-1407_8e3461da-7a74-46b4-9a07-c7ff65b3d107SPL ID 8e3461da-7a74-46b4-9a07-c7ff65b3d107SPL set ID 792d8b51-3815-44d2-a20e-b494a9d0e055RxCUI 858733, 858751UNII 724L30Y2QR
- Pharmacologic class
- Bile Acid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771140701followed by a unit qualifier and the quantityPackage 70771-1407-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Ursodiol tablets, 250 mg and 500 mg are indicated for the treatment of patients with primary biliary cholangitis (PBC). Ursodiol tablets, 250 mg and 500 mg are bile acids indicated for the treatment of patients with primary biliary cholangitis. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 70771-1407
- What is NDC 70771-1407?
- 70771-1407 is the product NDC for Ursodiol, Ursodiol 250 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ursodiol.
- What is the active ingredient?
- Ursodiol.
- Who is the labeler?
- Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ursodiol?
- 41 other product NDCs are listed under this name. See all Ursodiol NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Ursodiol products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | AvPAK | 50268-864 | 50268-0864-13 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | NorthStar Rx LLC | 72603-613 | 72603-0613-01 |
| Ursodiol | Ursodiol 250 mg/1 | Tablet, Film coatedOral | Cardinal Health 107, LLC | 55154-2633 | 55154-2633-00 |
| Ursodiol | Ursodiol 500 mg/1 | Tablet, Film coatedOral | AvKARE | 42291-931 | 42291-0931-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | AvKARE | 42291-923 | 42291-0923-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Bryant Ranch Prepack | 72162-2619 | 72162-2619-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | PuraCap Laboratories, LLC | 24658-999 | 24658-0999-10 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Strides Pharma Science Limited | 64380-844 | 64380-0844-0464380-0844-0664380-0844-07 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | Laurus Labs Limited | 42385-946 | 42385-0946-01 |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | AvPAK | 50268-797 | 50268-0797-15 |
Other NDCs under ANDA 211145
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ursodiol | Ursodiol 250 mg/1 | TabletOral | American Health Packaging | 60687-527 |
| Ursodiol | Ursodiol 250 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1127 |
| Ursodiol | Ursodiol 500 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1128 |
| Ursodiol | Ursodiol 500 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1408 |